UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

8 hedge funds and large institutions have $2.16M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
4
Closed
2
Calls
$2K
Puts
$384K
Net Calls
-$382K
Net Calls Change
-$1.06M
Name Holding Trade Value Shares
Change
Shares
Change %
VF
1
Virtu Financial
New York
$961K -$600K -13,593 -38%
Jane Street
2
Jane Street
New York
$610K -$1.77M -40,000 -74%
TRCT
3
Tower Research Capital (TRC)
New York
$318K -$64.4K -1,455 -17%
UBS Group
4
UBS Group
Switzerland
$144K +$53.9K +1,224 +60%
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$44K +$44K +1,000 New
Morgan Stanley
6
Morgan Stanley
New York
$36K -$4.47K -100 -11%
LTFS
7
Ladenburg Thalmann Financial Services
Florida
$32K
AIM
8
Anchor Investment Management
South Carolina
$12.2K
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
-$790K -23,744 Closed
CG
10
Cutler Group
California
-$3K -100 Closed